Evolent Health, Inc. (EVH)
- Previous Close
8.82 - Open
8.81 - Bid 8.80 x 800
- Ask 8.80 x 900
- Day's Range
8.53 - 8.85 - 52 Week Range
8.35 - 33.63 - Volume
1,799,841 - Avg. Volume
2,706,033 - Market Cap (intraday)
1.037B - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
-- - EPS (TTM)
-1.23 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.31
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
www.evolent.com4,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EVH
View MorePerformance Overview: EVH
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVH
View MoreValuation Measures
Market Cap
1.04B
Enterprise Value
1.66B
Trailing P/E
--
Forward P/E
22.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.42
Price/Book (mrq)
1.11
Enterprise Value/Revenue
0.69
Enterprise Value/EBITDA
50.94
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.54%
Return on Assets (ttm)
-0.04%
Return on Equity (ttm)
-9.24%
Revenue (ttm)
2.4B
Net Income Avi to Common (ttm)
-140.48M
Diluted EPS (ttm)
-1.23
Balance Sheet and Cash Flow
Total Cash (mrq)
246.55M
Total Debt/Equity (mrq)
77.09%
Levered Free Cash Flow (ttm)
2.23M